Conversely, metal chelators can regulate metal toxicity, dissolve these proteinaceous deposits from post-mortem AD brain tissue, and attenuate cerebral Aβ amyloid burden in APP transgenic mouse models of AD [12,13,14]. This evidence concerns the gene APP and Alzheimer disease.